Fresenius Medical Care AG & Co. KGaAFMSNYSE
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank14
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P14
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-13.89%
2024-20.90%
20231.46%
20223.55%
202113.94%
202015.32%
201925.39%
20182.29%
2017-14.95%
201620.29%